| Medical and Health Sciences | Lifetime | 800 | DE 32 | 99.96 |
| Medical and Health Sciences | 2021-2025 | 234 | DE 12 | 99.96 |
| Medical Physiology | Lifetime | 75 | DE 4 | 99.88 |
| Epidemiology | Lifetime | 101 | DE 5 | 99.85 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 449 | DE 17 | 98.65 |
| Clinical Pharmacology | Lifetime | 580 | DE 19 | 97.51 |
| Cardiology and Cardiovascular Medicine | Lifetime | 974 | DE 50 | 97.61 |
| Pharmacy | Lifetime | 466 | DE 13 | 93.17 |
| Endocrine and Autonomic Systems | Lifetime | 400 | DE 14 | 93.39 |
| Medical Physiology | 2021-2025 | 14 | DE 1 | 99.79 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 65 | DE 4 | 99.05 |
| Clinical Pharmacology | 2021-2025 | 83 | DE 4 | 97.15 |
| Epidemiology | 2021-2025 | 317 | DE 13 | 97.44 |
| Molecular Biology | 2021-2025 | 525 | DE 30 | 97.31 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 299 | DE 19 | 97.32 |
| Surgery | 2021-2025 | 475 | DE 26 | 96.29 |
| Pharmacy | 2021-2025 | 59 | DE 1 | 91.86 |
| Genetics | 2021-2025 | 526 | DE 27 | 85.16 |
| Endocrine and Autonomic Systems | 2021-2025 | 149 | DE 8 | 76.38 |
| Cancer Research | 2021-2025 | 424 | DE 28 | 68.08 |
| Adipose Tissue and Metabolism | Lifetime | 15 | DE 1 | 99.92 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 17 | DE 2 | 99.86 |
| Cardiovascular Disease and Adiposity | Lifetime | 19 | DE 1 | 99.85 |
| Diet and metabolism studies | Lifetime | 73 | DE 3 | 99.79 |
| Apelin-related biomedical research | Lifetime | 8 | DE 3 | 99.31 |
| Regulation of Appetite and Obesity | Lifetime | 54 | DE 4 | 99.39 |
| Pharmacology and Obesity Treatment | Lifetime | 31 | DE 2 | 99.38 |
| Metabolism, Diabetes, and Cancer | Lifetime | 132 | DE 6 | 99.34 |
| Diabetes Treatment and Management | Lifetime | 206 | DE 16 | 99.16 |
| Peroxisome Proliferator-Activated Receptors | Lifetime | 210 | DE 10 | 98.24 |
| Bariatric Surgery and Outcomes | Lifetime | 173 | DE 3 | 97.90 |
| Dietary Effects on Health | Lifetime | 109 | DE 3 | 97.41 |
| Retinoids in leukemia and cellular processes | Lifetime | 422 | DE 23 | 96.56 |
| Lipid metabolism and disorders | Lifetime | 312 | DE 14 | 96.52 |
| Exercise and Physiological Responses | Lifetime | 662 | DE 21 | 95.54 |
| Adipose Tissue and Metabolism | 2021-2025 | 1 | DE 1 | 99.83 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 1 | DE 1 | 99.79 |
| Diet and metabolism studies | 2021-2025 | 6 | DE 1 | 99.84 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 4 | DE 1 | 99.68 |
| Bariatric Surgery and Outcomes | 2021-2025 | 24 | DE 1 | 98.54 |
| Pharmacology and Obesity Treatment | 2021-2025 | 10 | DE 1 | 98.70 |
| Diabetes Treatment and Management | 2021-2025 | 92 | DE 6 | 98.86 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 45 | DE 4 | 98.56 |
| Regulation of Appetite and Obesity | 2021-2025 | 32 | DE 8 | 96.68 |
| Diabetes Management and Research | 2021-2025 | 906 | DE 46 | 90.40 |
| Diabetes and associated disorders | 2021-2025 | 700 | DE 48 | 88.11 |
| Pancreatic function and diabetes | 2021-2025 | 979 | DE 51 | 86.81 |
| Dietary Effects on Health | 2021-2025 | 333 | DE 17 | 81.67 |
| Obesity and Health Practices | 2021-2025 | 438 | DE 6 | 81.42 |
| Diet, Metabolism, and Disease | 2021-2025 | 945 | DE 20 | 81.15 |
| Endoplasmic Reticulum Stress and Disease | 2021-2025 | 671 | DE 52 | 76.36 |
| Fibroblast Growth Factor Research | 2021-2025 | 346 | DE 17 | 74.29 |
| Nutrition, Genetics, and Disease | 2021-2025 | 658 | DE 28 | 73.10 |
| GDF15 and Related Biomarkers | 2021-2025 | 540 | DE 36 | 56.49 |
| Nuclear Structure and Function | 2021-2025 | 790 | DE 47 | 52.47 |
| Apelin-related biomedical research | 2021-2025 | 476 | DE 13 | 50.87 |
| Biotin and Related Studies | 2021-2025 | 420 | DE 29 | 34.82 |